Algert Global’s Enzo Biochem, Inc. ENZ Stock Holding History

Algert Global’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,712	Closed	-$49K	–	1143
2021 Q3	$49K	Buy	+13,712	New	+$45.7K	0.01%	1000
2019 Q1	–	Sell	-58,171	Closed	-$162K	–	406
2018 Q4	$162K	Sell	58,171 -282,987	-83%	-$927K	0.05%	341
2018 Q3	$1.41M	Buy	341,158 +86,138	+34%	+$391K	0.3%	121
2018 Q2	$1.32M	Buy	255,020 +40,819	+19%	+$249K	0.27%	137
2018 Q1	$1.17M	Buy	214,201 +169,838	+383%	+$1.2M	0.23%	165
2017 Q4	$362K	Buy	+44,363	New	+$424K	0.09%	243

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's ENZ Position: Q4 2021 in Review

Algert Global sold out of Enzo Biochem, Inc. (ENZ) in Q4 2021, closing a stake of 13,712 shares — an estimated $49K sold.

Algert Global first reported a position in ENZ in Q4 2017 and held it in 6 quarters. The position peaked at $1.41M in Q3 2018. 59 funds tracked by Wall St. Rank hold ENZ as of Q4 2021.

Algert Global reported no remaining Enzo Biochem, Inc. position as of Q4 2021 after selling out during the quarter.
Algert Global sold 13,712 Enzo Biochem, Inc. shares in Q4 2021, an estimated $49K.
Algert Global first reported a position in Enzo Biochem, Inc. in Q4 2017 and held it in 6 quarters.
Algert Global's Enzo Biochem, Inc. position peaked at $1.41M in Q3 2018.
59 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2021.

Based on Algert Global's 13F filing for Q4 2021, filed 14 Feb 2022.